title: Symptomatic Secondary Polycythemia Induced by Anti-VEGF Therapy for the Treatment of Metastatic Renal Cell Carcinoma: A Case Series and Review.
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA. Electronic address: wwang3@hmc.psu.edu.
authors: Wenge
authors: W
authors: Wang
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Jihua
authors: J
authors: Cheng
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Carol
authors: C
authors: Mallon
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Mohammed Y
authors: MY
authors: Al-Marrawi
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Sheldon
authors: S
authors: Holder
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Monika
authors: M
authors: Joshi
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Matthew
authors: M
authors: Kaag
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Giampaolo
authors: G
authors: Talamo
authors: Hematology-Oncology and Urology Divisions, Penn State Milton S. Hershey Medical Center and Cancer Institute, Hershey, PA.
authors: Joseph J
authors: JJ
authors: Drabick
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D018962:Phlebotomy; D011086:Polycythemia / Q000139:chemically induced* / Q000628:therapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A
keywords: Axitinib; Bevacizumab; Erythropoietin; Hypoxia induced factor; Pazopanib; Phlebotomy; Sorafenib; Tyrosine kinase inhibitors